• / Free eNewsletters & Magazine
  • / My Account
Home>Authors>Mitchell Corwin

Mitchell Corwin

  1. 10 for ’14

    On Sunday, Caremark RX CMX announced that its board unanimously rejected Express Scripts' ESRX bid for the company and will continue to pursue the merger with CVS CVS. We are not changing our fair value estimates as a result of this announcement, since our estimates for all firms assume that CVS ...

©2017 Morningstar Advisor. All right reserved.